Approval · Notice of Compliance 35742 · 2025
EBIXA: Notice of Compliance 35742
Issued July 25, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35742
- Date
- July 25, 2025
- Company
- Lundbeck Canada IncSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to Patient Medication Information. Update to package labels. Update to package insert. Change in the composition of a dosage form
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EBIXA | Not yet assigned | — |
Medicinal ingredients
- MEMANTINE HYDROCHLORIDE 10 MG per TAB